All In Biotech

Drug Trial Radar · NCT05080465

Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis

Long Term Follow up Autologous Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis

Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

700

Actual

Start

Dec 2, 2018

Primary completion

Oct 7, 2024

Study completion Jan 30, 2025

Sponsor

Lead sponsor
Ukraine Association of BiobankAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 69 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to assess safety and preliminary clinical activity of treatments of liver cirrhosis in patients with caused by Hepatitis C and Hepatitis B or Nonalcoholic Steatohepatitis of Mesenchymal stem cell. Patients who will be enrolled in the study will be under supervision and monitoring to ensure clinical significance

Conditions

  • Liver Cirrhosis

Interventions

  • Autologous BM MSCBiological

    A total of 100-200ml will be harvested from the subject, in either a single or multiple punctures. This will be processed for autologous MSC infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MR ElastographyTime frame: Change from Baseline (Day 0) until 40 weeks
  2. The level of serum alanine aminotransferase (ALT)Time frame: Change from Baseline (Day 0) until 40 weeks
  3. Clinical ExaminationTime frame: Change from Baseline (Day 0) until 40 weeks
  4. The level of glomerular filtration rate (GFR)Time frame: Change from Baseline (Day 0) until 40 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institute of Bio-Stem Cell Rehabilitation

    Kharkiv, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.